Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2016.06.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

New Insights Into the Prognostic Value of Ki-67 Labeling Index in Patients With Triple-Negative Breast Cancer

Oncotarget
Oncology
2016English

Estrogen Receptor Positive/Progesterone Receptor Negative Breast Carcinomas: A Subgroup Deserves Particular Interest

Bezmialem Science
2015English

Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2013English

BCT Score Predicts Chemotherapy Benefit in Asian Patients With Hormone Receptor-Positive, HER2-negative, Lymph Node-Negative Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Impact on Survival of Estrogen Receptor, Progesterone Receptor and Ki-67 Expression Discordance Pre- And Post-Neoadjuvant Chemotherapy in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology
Forensic MedicinePathology
2016English

Lymph Node Metastasis and High Serum CEA Are�important Prognostic Factors in Hormone Receptor Positive and HER2 Negative Breast Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy